Though their use is supported by various professional guidelines, their injectable route of administration has been considered a barrier to widespread adoption
DAY 2 Session 5: Device Design, User Interface, Human Factors, and Quality Format: Presentations and a Panel Discussion with Q&A (Virtual and In-Person Attendees) This session examines how device user interface differences in GLP-1 products affect substitutability, bioequivalence, and FDA expectations for Comparative analyses (CA) and Comparative Use Human Factors (CUHF) studies, and addresses device engineering and drug-device compatibility considerations that impact performance, bioequivalence, and ANDA review for GLP-1 generic combination products
The most productive journals were Osteoporosis International (1,679, 6.4%), Bone (832, 3.2%), and the Journal of Bone and Mineral Research (727, 2.8%)
Facing a bill of $1,000 a month and determined to keep taking the medication, Delp looked to the north
Seeing visible changes in the face after weight loss is a common occurrence